Flyover Capital closes its Tech Fund II over $60M, targeting new seed, post-seed startups
September 2, 2021 | Startland News Staff
Tech startups raising seed and post-seed funding will benefit most from the close of Flyover Capital Fund II, the venture capital firm said, announcing Thursday its oversubscribed close.
“The oversubscribed fund brings Flyover Capital’s total assets under management to approximately $110 million,” the Overland Park-based venture capital firm said in a release, outlining plans for its more than $60 million Tech Fund II.
“The new fund will make initial investments at the seed and post-seed stages, targeting initial equity investments between $0.5 million to $2 million in rounds between $1 and $5 million.”
Fund II closed more than $10 million over its target, the venture firm noted, adding it expects to see the same success as its original fund, which invested in tech companies across 10 states and boasts more than $100 million in assets under management. Six startups in the firm’s portfolio have exited — including Kansas City-based EyeVerify (now Zoloz) and RiskGenius.
Other metro companies having received investment from Flyover Capital include Innara Health, Lending Standard, and TripleBlind.
Click here to learn more about Flyover Capital or its portfolio.
“We set out to invest in the next generation of technology success stories outside of the traditional tech hubs,” said Thad Langford, founder and managing partner.
“The longstanding support by our limited partners has allowed us to execute towards that mission. We look forward to continuing to identify world class entrepreneurs, build a differentiated brand, and support founding teams that are creating incredible companies poised to transform the largest industries in Middle America.”
The ability of tech founders to build their companies in cities like Kansas City regardless of its geographic location has strengthened the work of Flyover Capital in its seven years of operation, added Keith Molzer, founder and managing partner.
The firm’s investment team, led by Dan Kerr, who recently became a partner within the firm, is expected to focus heavily on business-to-business and enterprise software focused ventures in its second run.
“We have seen continued growth of the early-stage ecosystem and expect increased remote work and relocations to reinforce the region’s human startup capital,” Kerr said.
Strong support from family offices and institutional investors made the close of Fund II possible, Flyover Capital said, adding it reinforces the firm’s thesis and confirms its momentum in the midwest venture-space.
Featured Business
2021 Startups to Watch
stats here
Related Posts on Startland News
Court clutter on trial: Olathe legal tech startup puts boxes of evidence one touch away
A Kansas-built innovation is reshaping courtroom outcomes with its one-touch trial prep platform that already has helped attorneys secure billions in verdicts with ease, said Jay Rutler. “I have a reputation for solving complicated problems,” added Rutler, founder and CEO of Litigen, and founder of ICON, a casino chip manufacturer. “A friend of mine, a…
Why a City Market favorite is jumping the state line — to the food court at Oak Park Mall
Its Brazilian dishes — using recipes the owners grew up eating in São Paulo — have been a City Market draw for more than a decade. Now Taste of Brazil restaurant is expanding to Johnson County, but as a quick-serve kiosk with a limited menu. Taste of Brazil Express plans a late September opening in…
Spiced side hustle gives this Kansas culinary teacher a kick (and a growing market)
Richard Wilks is bringing heat to Kansas’ food scene. A chef and community-builder at heart, Wilks created Burro, a line of chili and garlic crunch oils, sauces, and seasonings designed to fuel real connection around the table. His growing lineup can be spotted at the Overland Park Farmers Market, where loyal customers keep coming back…
Animal health innovators: Building on a new frontier means do-overs, even when you got it right first
Kansas City-based ELIAS Animal Health earned full USDA approval for its bone cancer therapy for dogs earlier this year, but the road to commercialization has been long and anything but straight, Tammie Wahaus shared. The veteran CEO shared her story of pivots — including switching from human health to animal health and adapting to ever-changing…
